The objectives of this study are to evaluate the safety, tolerability and preliminary efficacy of two dose levels of INS37217 (denufosol tetrasodium) Inhalation Solution in patients with cystic fibrosis (CF) lung disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
72
respiratory function
adverse events
change in standard safety parameters
respiratory symptoms via questionnaire
pulmonary exacerbation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.